Magnetic Resonance Imaging (MRI) Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Global Magnetic Resonance Imaging (MRI) Market Trends and Insights

Rising Chronic-Disease Imaging Demand

Non-communicable diseases caused 74% of global deaths in 2024, pushing clinicians to favor MRI’s radiation-free profile for repeat monitoring. Cardiac MRI is displacing nuclear stress tests after studies showed gadolinium-enhanced protocols reduce false positives by 40%.^{[1]Steve R. Ommen, “2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy,” Circulation, ahajournals.org} Oncology teams now rely on diffusion-weighted and dynamic contrast-enhanced sequences to track tumor response sooner than CT can reveal anatomic change. Neurologists use 7 T systems to visualize lesions invisible at 1.5 T, integrating MRI as a lifelong biomarker platform rather than a one-off diagnostic. This clinical migration embeds recurring volumes into the Magnetic Resonance Imaging market. 

Expanding Geriatric Population Base

The population aged 65 years and higher globally is projected to reach 2.2 billion by the late 2070s. By the mid-2030s, it is projected that there will be 265 million persons aged 80 years or older.^{[2]United Nations Department of Economic and Social Affairs, “World Population Prospects 2024: Summary of Results,” United Nations, un.org} Orthopedic MRI demand is accelerating as surgeons need precise joint images before replacements, and dementia prevalence is doubling every two decades, requiring amyloid-sensitive sequences to guide disease-modifying drugs approved in 2024. Elderly patients prefer MRI over CT to avoid ionizing radiation, although frailty elongates acquisition time, making AI-accelerated protocols crucial to maintain throughput. These factors collectively enlarge the Magnetic Resonance Imaging market.

AI-Enhanced High-Field MRI Innovations

Deep learning reconstruction trims brain and spine scan times by up to 60% while maintaining >95% diagnostic confidence, as shown with Siemens Deep Resolve in 2024.^{[3]Siemens Healthineers, “Deep Resolve: Unrivaled Speed in MRI,” Siemens Healthineers, siemens-healthineers.com} Canon’s AiCE leverages 10 million annotated images to deliver sub-1 mm isotropic musculoskeletal studies without extra scan time. GE’s AIR Recon DL processes k-space directly, recovering signal previously lost to motion. These tools let a 1.5 T magnet emulate near-3 T performance, shifting differentiation in the Magnetic Resonance Imaging market from magnet strength to algorithm strength.

Helium-Free Upgradeable Magnet Platforms

Spot helium surpassed USD 30 per liter in 2024 following geopolitical supply shocks, tripling refill costs. Siemens DryCool eliminated 1,500 liters per system, saving USD 50,000 annually. Philips BlueSeal cuts helium to 7 liters, enabling sites without cryogen infrastructure. GE’s Freelium retrofit extends refill intervals to a decade. These advances reduce ownership costs and speed upgrades, reinforcing expansion of the Magnetic Resonance Imaging market.

High Capital & Service Costs

A 3 T system lists at USD 2.5–3 million and annual service can exceed USD 300,000. Construction for RF shielding adds another USD 500,000–1 million, extending payback to a decade in low-volume regions. Even a USD 500,000 portable unit needs three years at eight scans per day to break even. Pay-per-scan leases help, but they demand consistent patient flow, curbing Magnetic Resonance Imaging market adoption in budget-constrained zones.

Reimbursement-Pressure Headwinds

CMS cut the 2025 physician fee schedule by 2.83%, trimming MRI payments USD 15–30 per study. The U.K. NHS held imaging budgets flat despite 12% higher referrals, stretching wait times. Prior-authorization hurdles by private insurers delay exams and reduce volumes by around 8%. Providers respond by emphasizing higher-acuity studies that offset lower margins, yet pricing pressure still weighs on the Magnetic Resonance Imaging market.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Product Type: Software Accelerates Revenue Expansion

Software revenue is on track for a 10.55% CAGR through 2031, more than double hardware growth, as cloud PACS and AI reconstruction shift value from equipment to subscriptions. Hardware still commanded 68.35% of the Magnetic Resonance Imaging market share in 2025, supported by an installed fleet exceeding 40,000 scanners. Software add-ons like GE AIR Recon DL, priced at USD 150,000, enable clinics to defer USD 2 million magnet upgrades while achieving comparable image quality. The Magnetic Resonance Imaging market size for services is stable but sees margin erosion as helium-free designs reduce cryogen maintenance bills.

Vendor business models now center on recurring revenue: Philips SmartSpeed and Siemens syngo.via offer continual algorithm updates and cloud storage under multi-year contracts. This arrangement secures predictable cash flows and diffuses disruptive software-only entrants that license algorithms directly to providers. Hardware innovation is concentrating on modular, upgradeable designs such as Canon’s Vantage Orian 3 T, shortening refresh cycles from 10 to five years and aligning expenditures to clinical innovation.

By Architecture Type: Open Systems Ease Patient Access

Closed scanners provided 74.24% of 2025 revenue due to superior field homogeneity, yet open systems should compound at 8.34% per year as bariatric and claustrophobic populations rise. Claustrophobia causes 10–15% of incomplete scans, often requiring sedation that adds USD 500–1,000 per case. Open C-shaped magnets relieve anxiety, cut scan failures by 60%, and accommodate patients exceeding 350 lb. Extremity-dedicated systems are growing in sports medicine clinics where sub-USD 1 million pricing fits practice budgets.

Mobile 1.5 T trailers and cart-based 0.064 T units such as Hyperfine Swoop widen access in remote regions. FDA and IAC validations secured in 2024 resolved payer uncertainty, enabling Medicare coverage and catalyzing demand. As hospitals assemble fleets—a 3 T closed, an open pediatric, a portable ICU unit—architecture choices in the Magnetic Resonance Imaging market become application-specific rather than monolithic.

By Field Strength: 3 T Gains Dominance

Mid-field devices (0.5–1.5 T) held 46.23% in 2025, reflecting their general-purpose utility. High-field 3 T scanners are projected to expand at 7.25% CAGR, buoyed by cardiology and prostate protocols that favor faster, finer resolution. AI reconstruction lets 1.5 T systems mimic 3 T image quality but at longer scan times, limiting throughput at busy centers. Portable low-field units are carving emergency and rural niches, and fewer than 100 ultra-high-field 7 T systems remain concentrated in academic labs for epilepsy and multiple-sclerosis studies.

Suppliers hedge by offering upgrade paths: Philips Ingenia Elition can convert from 1.5 T to 3 T in the field, letting customers align magnet strength with evolving reimbursement and clinical demand. This flexibility supports replacement in the Magnetic Resonance Imaging market while containing initial capital exposure.

By Application: Cardiology Leads Growth

Neurology remained the largest slice in 2025, but cardiac MRI is the growth engine, targeting an 8.02% CAGR through 2031. The American College of Cardiology granted cardiac MRI a Class I recommendation for myocarditis and Class IIa for coronary ischemia assessment, expanding addressable volume by roughly 2 million annual U.S. studies. Parametric mapping and stress perfusion protocols command USD 800-1,500 per exam, outpricing routine brain or spine scans and improving margins for imaging centers.

Musculoskeletal imaging benefits from AI cartilage and ligament segmentation that accelerates reads by 40%, while oncology expands with DWI and DCE sequences that spot therapy response early. Breast MRI gained momentum after the 2024 U.S. density-notification mandate, accelerating supplemental screening volumes. This richer case mix raises average reimbursement across the Magnetic Resonance Imaging market size for applications.

By End User: Ambulatory Centers Capture Momentum

Hospitals retained 58.89% revenue in 2025, yet ambulatory surgical centers are on track for a 9.03% CAGR as orthopedic and spine procedures migrate to cost-efficient facilities. Imaging chains backed by private equity leverage network scale for equipment discounts and radiologist sharing. Research institutions, though small in revenue, influence adoption of AI and 7 T protocols that later diffuse into routine care.

Veterinary demand is emerging as pet insurance penetration rises to 4% in the U.S., with dedicated 1.5 T open systems installed at specialty clinics. Portable MRI further decentralizes imaging to urgent-care clinics and skilled-nursing facilities, broadening the end-user base inside the Magnetic Resonance Imaging market.

Geography Analysis

North America supplied 37.86% of global revenue in 2025, benefiting from academic research hubs and early 7 T clinical adoption. Yet CMS cuts and site-neutral payments encourage a shift of volumes to freestanding centers, altering revenue distribution. Canada’s public–private partnerships trimmed wait times by up to 20%, while Mexican border clinics lure U.S. patients with 40-60% lower pricing.

Asia-Pacific is the Magnetic Resonance Imaging market’s fastest-growing territory, pegged at an 8.91% CAGR. United Imaging deployed more than 200 uMR Omega 3 T scanners by 2024, leveraging 30-40% price gaps versus Western rivals. India’s USD 6.9 billion Ayushman Bharat allocation channels new installations toward district hospitals, compressing referral delays. Japan’s median age of 49 and focus on neurology anchor high-field demand, while South Korea banks on AI algorithms tuned to local population traits. Australia earmarked AUD 500 million (USD 330 million) for radiology upgrades, centering on 3 T equipment.

In Europe, budget-capped national systems tighten prior authorization and prolong replacement cycles. Germany’s statutory insurers narrowed MRI indications, slashing volumes 5-8% in 2024. The U.K.’s flat imaging budget despite rising referrals lengthens queues. Southern Europe deploys portable units for sparsely populated regions to improve access without full-scale installations. The Middle East purchases 3 T and 7 T systems for new tertiary hospitals, while Sub-Saharan Africa relies heavily on mobile trailers due to thin infrastructure. South American markets tread cautiously, hampered by currency swings and import tariffs that favor refurbished equipment over new purchases.

Regulatory Landscape

MRI systems and related accessories continue to be shaped by medical-device regulations and MRI-specific consensus standards, which affect safety labeling, electromagnetic compatibility, and what vendors can claim for clinical performance. In 2026, MRI-environment safety marking gained an updated anchor with EN IEC 62570:2026-01 (effective January 1, 2026), while EN IEC 60601-2-33:2026 listed as effective from June 1, 2026 reinforced requirements for conformity and procurement specifications across MR equipment.

Regulatory attention is also tightening around the software and AI used in radiology workflows. In the United States, the FDA published a final order effective June 17, 2026, classifying radiological machine learning-based quantitative imaging software with predetermined change control plans into Class II (special controls), which supports lifecycle updates within a defined control framework. Europe continues to operate under the EU Medical Device Regulation (MDR) (EU) 2017/745 as the primary framework, alongside ongoing 2025/2026 reform proposals aimed at improving coordination and expert-panel capacity, which influences certification timelines and the evidence expectations for MRI hardware as well as software-as-medical-device components.

Market Opportunities and Future Outlook

A clear opportunity is emerging around tighter pairing of faster acquisition, reduced contrast dependence, and workflow automation, with hardware roadmaps increasingly tied to software upgrades rather than full system replacements. Multiple 2026 U.S. FDA 510(k) clearances across GE HealthCare, Siemens Healthineers, Philips, and Fujifilm point to an ongoing replacement-and-upgrade cycle in 1.5T and 3T platforms, and to a higher attach rate for deep learning reconstruction and workflow capabilities as billable performance differentiators. Philips Titanion, announced at ISMRM 2026 with ultra-high-gradient performance (150 mT/m), also points to demand for quantitative and whole-body biomarker imaging where centers differentiate on advanced protocols.

Contrast-sparing cardiac MRI is another practical adoption lever for new protocol packages and AI add-ons. In July 2026, a prospective multicentre trial from the University of Oxford reported that Virtual Native Enhancement (VNE) AI could mimic contrast-enhanced cardiac MRI without dye injections in two thirds of heart attack patients, creating a more scalable pathway for outpatient deployment and for patients with contrast limitations. On the supply side, sustainability and infrastructure simplification are supporting additional installation settings. Siemens Healthineers plans a 56,000 square meter MRI production facility in Oxfordshire focused on DryCool technology (helium reduction from 1,500 liters to under one liter), which aligns with procurement programs that prioritize reduced site-prep burden and resilience to helium supply volatility, particularly for mobile and distributed imaging networks.